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Abstract
Background: Heritable electrocardiographic (ECG) and heart rate variability (HRV) measures, reflecting pacemaking,
conduction, repolarization and autonomic function in the heart have been associated with risks for cardiac arrhythmias.
Whereas several rare monogenic conditions with extreme phenotypes have been noted, few common genetic factors
contributing to interindividual variability in ECG and HRV measures have been identified. We report the results of a
community-based genomewide association study of six ECG and HRV intermediate traits.
Methods: Genotyping using Affymetrix 100K GeneChip was conducted on 1345 related Framingham Heart Study
Original and Offspring cohort participants. We analyzed 1175 Original and Offspring participants with ECG data (mean
age 52 years, 52% women) and 548 Offspring participants with HRV data (mean age 48 years, 51% women), in relation
to 70,987 SNPs with minor allele frequency ≥ 0.10, call rate ≥ 80%, Hardy-Weinberg p-value ≥ 0.001. We used
generalized estimating equations to test association of SNP alleles with multivariable-adjusted residuals for QT, RR, and
PR intervals, the ratio of low frequency to high frequency power (LF/HFP), total power (TP) and the standard deviation
of normal RR intervals (SDNN).
Results: Associations at p < 10-3 were found for 117 (QT), 105 (RR), 111 (PR), 102 (LF/HF), 121 (TP), and 102 (SDNN)
SNPs. Several common variants in NOS1AP (4 SNPs with p-values < 10-3; lowest p-value, rs6683968, p = 1 × 10-4) were
associated with adjusted QT residuals, consistent with our previously reported finding for NOS1AP in an unrelated sample
of FHS Offspring and other cohorts. All results are publicly available at NCBI's dbGaP at http://www.ncbi.nlm.nih.gov/
projects/gap/cgi-bin/study.cgi?id=phs000007.
Conclusion: In the community-based Framingham Heart Study none of the ECG and HRV results individually attained
genomewide significance. However, the presence of bona fide QT-associated SNPs among the top 117 results for QT
duration supports the importance of efforts to validate top results from the reported scans. Finding genetic variants
associated with ECG and HRV quantitative traits may identify novel genes and pathways implicated in arrhythmogenesis
and allow for improved recognition of individuals at high risk for arrhythmias in the general population.
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Background
Quantitative non-invasive measures of cardiac electrical
activity recorded in electrocardiographic (ECG) and heart
rate variability (HRV) studies are widely available in com-
munity-based samples and have been found to be predic-
tive of cardiovascular events including sudden cardiac
death [1-7]. Aggregation of these measures within families
suggests a heritable component.
Prior studies, including our own, have reported the herit-
ability of common indices of myocardial repolarization
and HRV measures. The heritability of electrocardio-
graphic QT interval duration, a measure of myocardial
repolarization, has been reported to be approximately
35%, indicating that 35% of the variability in adjusted QT
interval duration is attributable to heritable factors [8-11].
Electrocardiographic RR interval, or its inverse heart rate,
has been observed to have a heritability ranging from 32–
40% in family studies [12,13] and 54–77% in twin studies
[11,14,15]. Electrocardiographic PR interval has reported
heritability estimated at 34% [15]. We have previously
reported the heritability of HRV measures including the
ratio of low frequency to high frequency power, total
power and the standard deviation of normal RR intervals
[16].
The heritability of ECG and HRV traits suggests there is a
significant genetic component to the determination of
these measures of myocardial repolarization, sinus node
function, atrioventricular conduction, and autonomic
function. Rare variants in ion channel genes have been
implicated in rare Mendelian Long QT Syndromes. His-
torically, efforts to identify genetic determinants of com-
mon, complex traits have been focused on linkage or
association of a small number of such biologic candidate
genes with limited success and conflicting results.
Genome-wide association studies (GWAS) offer the
opportunity to test a large fraction of common genetic var-
iation using high-throughput genotyping arrays. Such
studies have recently identified genes previously unrecog-
nized to contribute to disease, including complement fac-
tor H and age-related macular degeneration [17], INSIG2
and obesity [18], and the IL23R and inflammatory bowel
disease [19]. To date the most convincing association with
an ECG or HRV trait is that of a common variant in
NOS1AP  with QT interval variation identified through
GWAS, reported by us in collaboration with others [20].
This study, using a fixed genotyping array to survey
100,000 variants, discovered a novel gene involved in
myocardial repolarization and demonstrated the power of
such unbiased methods to identify previously unrecog-
nized genes or pathways involved in cardiovascular phys-
iology. One such array, the Affymetrix 100K GeneChip
has been shown to capture about 30% of common genetic
variants among the European ancestry HapMap CEU sam-
ple [21]. We therefore sought to relate 70,987 common
genetic variants genotyped on this array to ECG and HRV
phenotypes in participants in the Framingham Heart
Study as a first step toward identifying genetic variants
that influence important cardiovascular traits.
Methods
Study sample
The Framingham Heart Study is a cohort of predomi-
nantly European ancestry; the study sample is more fully
described in the Overview Methods section [22]. ECG
traits were measured between 1968 and 1975 using the
entire sample of FHS Original and Offspring Cohort par-
ticipants (examination cycles 11 and 1, respectively) with
available measures, and free of prevalent coronary heart
disease, atrial fibrillation and anti-arrhythmic medication
use (n = 7356). The heritability sample for ECG analyses
comprised 1951 individuals in 355 pedigrees. HRV traits
were measured between 1983 and 1987 using the entire
sample of FHS Original (examination cycle 18) and Off-
spring Cohort participants (examination cycle 3) with
available measures, and free of prevalent myocardial inf-
arction, congestive heart failure, atrial fibrillation, diabe-
tes, and antihypertensive or cardioactive medication use
(n = 1966). The heritability sample for HRV traits com-
prised 747 subjects in 307 pedigrees. The sample exam-
ined for GWAS included the subset of individuals on the
FHS Related plates (n = 1175 for ECG analyses, n = 548 for
HRV analyses). Each study participant provided written
informed consent for genetic analyses and the study was
approved by the Boston University Medical Center Insti-
tutional Review Board.
Phenotype definition
Digital caliper measurements were made on scanned
paper ECGs recorded at 25 mm/sec, with good reproduc-
ibility as previously shown [9]. QT interval duration on
the ECG was taken from the onset of the QRS to the end
of the T wave or the nadir between the T wave and U wave
if present, as previously described [9]. The QT phenotype
was defined as the averaged, standardized residuals from
sex-, lead-(II, V2, V5) and cohort-specific linear regression
on age and RR interval. RR interval duration was meas-
ured as the time in msec from one R wave to the next R
wave. The RR phenotype was defined as the averaged,
standardized residuals from sex-, lead-(II, V2, V5), and
cohort-specific linear regression on age. PR interval dura-
tion was measured from the onset of the P wave to the
onset of the QRS interval on lead II only. The PR pheno-
type was defined as the standardized residual from sex-
and cohort-specific linear regression on age and RR inter-
val.BMC Medical Genetics 2007, 8(Suppl 1):S7 http://www.biomedcentral.com/1471-2350/8/S1/S7
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Heart rate variability measures were extracted from two
hour ambulatory ECG recordings as previously described
[16,23]. We excluded recordings with nonsinus rhythm,
>10% premature beats, <1 hour recording time, or proc-
essed time <50% recording time. Fast Fourier transform
analysis was performed on 100-second blocks of RR inter-
val data from 32 Hz recordings (Cardiodata Corp) sam-
pled at 180 samples/second (Mortara Instrument Co).
Power density spectra were averaged across all 100-second
blocks. HRV phenotypes include two frequency domain
measures, ratio of low frequency to high frequency power
(LF/HF) and total power (TP) and one time domain meas-
ure: standard deviation of normal RR intervals (SDNN).
The phenotype studied was the standardized, log-trans-
formed residuals from sex and cohort-specific linear
regression of HRV trait on age, heart rate, systolic and
diastolic blood pressures, coffee intake and alcohol intake
[23].
Genotyping and annotation
Affymetrix 100K SNP genotyping is described in the Over-
view Methods section [22]. Genotype annotation using
dbSNP and UCSC Genome Browser [24,25] are described
in the Overview Methods section [22].
Statistical analysis
The general statistical methods for linkage and GWA anal-
yses are described in the Overview Methods section [22].
Heritability was estimated using the variance components
methods implemented in SOLAR [26]. The primary anal-
ysis of SNP associations with the 6 ECG and HRV pheno-
types involved use of linear regression of minor allele
copy number (additive genetic model) on phenotype
using generalized estimating equations (GEE) to account
for relatedness among individuals as described in the
Overview [22]. Secondary analyses involved family-based
association testing using FBAT [27] and linkage using
SOLAR [25] after exact identity-by-descent estimation
using Merlin [28] on a subset of 11,200 SNPs and STRs.
Affymetrix 100K GeneChip SNPs tested for association
with phenotypes included the 70,987 autosomal SNPs
with minor allele frequency ≥ 10%, call rate ≥ 80% and
Hardy-Weinberg equilibrium p-value ≥ 0.001. For all
results, nominal p-values are shown, unadjusted for mul-
tiple tests. For positive control analyses of rs10494366, we
accessed HapMap CEU genotypes at the NOS1AP locus
December 11, 2005 (http://www.hapmap.org). Correla-
tion (r2) among HapMap CEU SNPs was determined
using HaploView 4.0 beta 11 (http://www.broad.mit.edu/
mpg/haploview).
Results
Clinical characteristics of the FHS sample of 1345 subjects
are presented in the Overview [22]. Table 1 displays the
variables that were studied in our analyses of ECG and
HRV traits. Further information on these traits can be
found at http://www.ncbi.nlm.nih.gov/projects/gap/cgi-
bin/study.cgi?id=phs000007.
ECG and HRV measures are heritable traits
We have previously shown in the Framingham Heart
Study that electrocardiographic QT interval duration,
adjusted for RR interval, age, and sex has substantial her-
itability. In the current study, including a subset from the
original report, heritability was estimated at 0.39 (Table
1) [9]. We have also previously shown that HRV pheno-
types show familial aggregation [16]; in the current report,
after adjustment for covariates, heritability estimates were
0.36 (LF/HF), 0.41 (TP), and 0.32 (SDNN) (Table 1). For
the electrocardiographic RR interval (inverse heart rate),
adjusted for age and sex, in the related sample of FHS orig-
inal and offspring participants, we observed a heritability
of 0.29. For the electrocardiographic PR interval, adjusted
for age, sex and RR interval, we observed a heritability of
0.34.
Association tests approximate the null distribution
After filtering all autosomal SNPs on call rate ≥ 80%,
minor allele frequency ≥ 0.10 and Hardy-Weinberg p-
value ≥ 0.001, we observed a distribution of the 70,987 p-
values that approximated a null distribution. The propor-
tions of p < 0.0001 or p < 0.001 averaged across all six
ECG and HRV phenotypes were 0.00018 and 0.0016,
respectively (Table 2). The proportion of tests with a 
p ≥ 0.10 was 0.89. The p-value distributions were stable
across increasingly stringent call rate thresholds and
showed only a minor trend toward fewer excess p-values
with increasing minor allele frequency (data not shown).
Genome-wide association results
Results can be found at http://www.ncbi.nlm.nih.gov/
projects/gap/cgi-bin/study.cgi?id=phs000007. From the
primary GEE analyses, the strongest associations for the
QT, RR and PR phenotypes were for SNPs rs10507380 (p
= 8.4 × 10-6), rs2179896 (p = 1.7 × 10-5), and rs882300 (p
= 3.2 × 10-7), respectively (Table 3). From the primary
GEE analyses, the strongest associations for LF/HF, TP,
SDNN were for SNPs rs1395479 (p = 6.9 × 10-6),
rs9315385 (p = 7.7 × 10-6), and rs2966762 (p = 2.0 × 
10-5), respectively (Table 3). SNP associations by GEE
analysis with nominal p < 10-3 were found for 117 (QT),
105 (RR), 111 (PR), 102 (LFHFP), 121 (TP), and 102
SNPs (SDNN).
Positive controls in NOS1AP support the promise of 
GWAS in this sample
We have previously reported the association of a common
variant rs10494366 (MAF 38%) in the NOS1AP gene with
adjusted QT interval variation in 3 independent cohorts,
including an unrelated set of Framingham Heart StudyBMC Medical Genetics 2007, 8(Suppl 1):S7 http://www.biomedcentral.com/1471-2350/8/S1/S7
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participants (on the Unrelated Plates), as part of a three-
stage genome-wide association study [20]. In the current
report, we have now validated the association of
rs10494366, genotyped on the Affymetrix 100K Gene-
Chip array, with QT interval duration in the Related Plate
set examined (nominal 2-sided p = 0.0009, rank in 100K
analysis #102, call rate 91%). Moreover, among the 117
SNPs on the array associated with QT with p < 0.001 there
were three additional associated SNPs that were in or near
NOS1AP,  all partially correlated with rs10494366:
rs6683968 (p = 0.0001, MAF 32%, 100K rank #10, r2 =
0.05 to rs10494366 in HapMap CEU, call rate 93%),
rs945713 (p = 0.0002, r2 = 0.35, MAF 42%, rank #23, call
rate 99%) and rs1932933 (p = 0.0004, r2 = 0.63, MAF
39%, rank #42, call rate 99%). For illustrative purposes,
we further considered a two-staged design in which one
genotyped all SNPs associated with the QT phenotype
with p < 0.001 (n = 117) found in the Related Plate set
100K analysis in an additional approximately 1500 inde-
pendent Framingham offspring cohort participants on the
unrelated plate set (the reverse of the order in which this
SNP was actually genotyped). In such a design the p-value
for SNP rs10494366 of 0.0009 would rise to a combined
p-value of 8.9 × 10-6 on joint analysis of the two samples.
Suggestive linkage results
We observed suggestive evidence of linkage to the follow-
ing phenotypes with LOD scores exceeding 2.2: LOD 2.50
on chromosome 3 (8.72 Mb) for QT interval, which has
previously been reported for a largely overlapping sample
using microsatellite markers [9]; 2.52 on chromosome 17
(74.21 Mb) for QT interval; 2.98 on chromosome 4
(124.75 Mb) for PR interval; 2.39 on chromosome 15
(75.51 Mb) for LF/HF, and 2.19 on chromosome 11 (4.40
Mb) for TP (Table 4).
Candidate genes and QT, RR interval traits
Because use of a genome-wide p-value threshold may be
overly conservative for candidate genes directly impli-
cated in cardiovascular physiology, we conducted a sec-
Table 1: Heritability of electrocardiographic and heart rate variability phenotypes examined in the Framingham 100K project
Phenotype Acronym Heritability sample Original Exam Offspring Exam Adjustment* Heritability† (SE)
Electrocardiographic phenotypes
QT sex-pooled QTPOOL 1951 11 1 Age, RR, sex, cohort 0.39 (0.04)†
QT men only QTMEN** 900 11 1 Age, RR, cohort 0.43 (0.08)
QT women only QTWOMEN** 1051 11 1 Age, RR, cohort 0.46 (0.04)
RR sex-pooled RRPOOL 1951 11 1 Age, sex, cohort 0.29 (0.04)
RR men only RRMEN** 900 11 1 Age, cohort 0.28 (0.08)
RR women only RRWOMEN** 1051 11 1 Age, cohort 0.31 (0.07)
PR sex-pooled PRAdjRRPOOL 1950 11 1 Age, RR, sex, cohort 0.34 (0.04)
Heart rate variability phenotypes
SDNN sex-pooled SDNNHRV 747 18 3 Age, heart rate, SBP, DBP, 
coffee & alcohol intake
0.32 (0.09)†
Total power sex-pooled TOTPWRHRV 747 18 3 Age, heart rate, SBP, DBP, 
coffee & alcohol intake
0.41 (0.10)†
Low frequency/high frequency 
power sex-pooled
LFHFHRV 747 18 3 Age, heart rate, SBP, DBP, 
coffee & alcohol intake
0.36 (0.10)†
All phenotypes for ECG and HRV traits are shown (including pre-specified secondary traits not examined for this report), including covariates adjusted for in linear regression 
models. Heritability estimates were generated in the superset of individuals with phenotype values in families (n ≤ 1951 for ECG traits, n ≤ 747 for HRV traits). For 
electrocardiographic traits there were 1175 individuals with genotypes and for heart rate variability there were 548 individuals with genotypes in the 100K analyses. All results 
are publicly available at http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?id=phs000007.
*Separate regression models were created by cohort and sex for ECG and HRV measures. †All heritability estimates <0.001.
**Prespecified secondary results in GWAS pipeline but not analyzed in this report (available at http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?id=phs000007). QT 
and HRV heritability estimates are consistent with previous reports in largely overlapping sample [9,16].
Table 2: Proportion of association results at different p-value thresholds
QT RR PR LF/HF Tot Power SDNN Average
p < 0.0001 0.000127 0.000197 0.000169 0.000281 0.000197 0.000112 0.000180
p < 0.001 0.00165 0.00149 0.00156 0.00143 0.00172 0.00145 0.00155
p > 0.10 0.891 0.886 0.882 0.895 0.895 0.893 0.890
Shown are the proportion of p-values for single SNP association tests using GEE which are more extreme than 0.0001, 0.001 and less extreme than 
0.10 for the six electrocardiographic and heart rate variability traits, after excluding SNPs with call rate <80%, minor allele frequency <10%, Hardy-
Weinberg equilibrium p-value < 0.001. The proportions observed closely approximate the proportions expected for a null distribution – 0.0001, 
0.001 and 0.90.BMC Medical Genetics 2007, 8(Suppl 1):S7 http://www.biomedcentral.com/1471-2350/8/S1/S7
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Table 3: Top GEE association results for electrocardiographic phenotypes
Trait SNP rank rs ID Chromosome Physical Position GEE p-value FBAT p-value Gene region (within 60 kb)
Top 8 QT interval SNPs
QT 1 rs10507380 13 26777526 8.4 × 10-6 0.665 RPL21
QT 2 rs2726920 11 108252434 4.2 × 10-5 0.865 DDX10
QT 3 rs763552 8 31564949 4.7 × 10-5 0.033 NRG1
QT 4 rs366307 5 150527337 4.9 × 10-5 0.104 ANXA6
QT 5 rs3858646 12 114038413 7.7 × 10-5 1.3 × 10-4
QT 6 rs1558139 19 15858564 8.2 × 10-5 6.0 × 10-5 CYP4F2
QT 7 rs1695508 7 28739796 8.5 × 10-5 0.002
QT 8 rs10495588 2 12153871 8.7 × 10-5 0.001
Top 8 RR interval SNPs
RR 1 rs2179896 14 53945264 1.7 × 10-5 0.032
RR 2 rs10518674 15 50105438 1.9 × 10-5 0.033 MAPK6
RR 3 rs321967 7 77959200 2.6 × 10-5 0.018 MAGI2
RR 4 rs4319121 8 53668308 3.6 × 10-5 0.571
RR 5 rs844429 10 80016392 4.5 × 10-5 0.032
RR 6 rs4345013 22 25706391 4.9 × 10-5 0.227
RR 7 rs2643191 3 165861395 5.2 × 10-5 2.5 × 10-4
RR 8 rs2932529 1 112905406 5.7 × 10-5 0.232 CAPZA1
Top 8 PR interval SNPs
PR 1 rs882300 2 136809987 3.2 × 10-7 0.133
PR 2 rs10518795 15 53131579 1.1 × 10-5 0.062
PR 3 rs7201988 16 9516007 3.0 × 10-5 0.001
PR 4 rs2096767 11 102296609 3.1 × 10-5 0.031 MMP13
PR 5 rs2831936 21 28922444 3.1 × 10-5 0.011
PR 6 rs10516736 4 82325666 5.1 × 10-5 0.014 BMP3
PR 7 rs4488182 11 41032137 5.4 × 10-5 0.008
PR 8 rs10489798 1 96957067 6.2 × 10-5 0.086 PTBP2
Top 8 LF/HF SNPs
LF/HF 1 rs1395479 4 178693340 6.9 × 10-6 0.034 NEIL3
LF/HF 2 rs2215456 12 40596176 1.3 × 10-5 0.002
LF/HF 3 rs1336938 13 88369006 1.6 × 10-5 0.003
LF/HF 4 rs796184 13 88515431 1.9 × 10-5 0.003
LF/HF 5 rs4669749 2 11643262 2.0 × 10-5 0.113 GREB1
LF/HF 6 rs1871841 8 13674417 2.1 × 10-5 0.015
LF/HF 7 rs721691 7 128485610 3.0 × 10-5 0.026
LF/HF 8 rs10509700 10 97884521 4.2 × 10-5 0.864
Top 8 Total Power SNPs
TP 1 rs9315385 13 35561302 7.7 × 10-6 0.031 DCAMKL1
TP 2 rs2276886 4 77285607 1.5 × 10-5 0.004 CXCL9
TP 3 rs726698 2 35366992 2.2 × 10-5 0.001
TP 4 rs1330948 13 106192232 2.4 × 10-5 0.016
TP 5 rs2283064 7 125719004 3.0 × 10-5 0.042 GRM8
TP 6 rs10515199 5 74135390 3.8 × 10-5 0.113
TP 7 rs1407709 1 184794336 4.0 × 10-5 0.042
TP 8 rs1723482 2 47318190 5.5 × 10-5 0.040
Top 8 SDNN SNPs
SDNN 1 rs2966762 5 109411118 2.0 × 10-5 0.024
SDNN 2 rs286751 5 107430837 2.1 × 10-5 4.1 × 10-5 FBXL17
SDNN 3 rs1013621 8 52963944 4.0 × 10-5 0.018
SDNN 4 rs1378506 5 109419129 4.5 × 10-5 0.110
SDNN 5 rs1866559 2 27247237 5.3 × 10-5 0.405 CGREF1
SDNN 6 rs2049161 18 4117583 5.9 × 10-5 0.036
SDNN 7 rs9297393 8 108356753 6.4 × 10-5 0.587 ANGPT1
SDNN 8 rs7012655 8 52740967 8.4 × 10-5 0.007
The top 8 association results for ECG phenotypes QT, RR and PR interval and for HRV phenotypes low frequency to high frequency power (LF/HF), total power (TP) and 
standard deviation of normal RR intervals (SDNN) are shown from a total 70,987 SNPs tested in additive genetic models using GEE. Chromosome and physical position using 
NCBI build 35 reference sequence (hg17) are shown. The corresponding FBAT p-value is shown (note: the number of informative families varies substantially). Genes within 
60 kb of a SNP are shown.BMC Medical Genetics 2007, 8(Suppl 1):S7 http://www.biomedcentral.com/1471-2350/8/S1/S7
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ondary analysis of SNPs within 60 kb of candidate genes
for ECG and HRV traits. Among 88 SNPs (MAF ≥ 0.10, call
rate ≥ 0.8, HWE p-value ≥ 0.001) in 9 genes implicated in
congenital Long QT Syndromes or QT interval duration,
only SNPs in NOS1AP had p < 0.05 for association with
QT interval duration (Table 5). Among 35 SNPs in 8
adrenergic receptor genes, SNPs with nominal p < 0.05
included two for RR interval, one for PR interval, none for
LF/HF power, two for total power and 7 for SDNN (Table
5).
Discussion
We confirmed the heritability of electrocardiographic RR
interval (inverse heart rate) and PR interval and repro-
duced our previously demonstrated findings that QT
interval and HRV traits are heritable in our community-
based European ancestry sample [9,16]. We have tested
70,987 common genetic variants (MAF ≥ 10%) for associ-
ation with six heritable electrocardiographic and heart
rate variability phenotypes, which have been shown to be
associated with adverse cardiovascular outcomes, includ-
ing sudden cardiac death. No result attained a genome-
wide significance threshold, such as p < 1 × 10-7 required
for Bonferroni correction for six traits and 70,987 SNPs.
The failure to achieve a genome-wide p-value threshold
reflects the massive penalty incurred by testing so many
hypotheses and the limited power to achieve such a p-
value given the modest effects of common variants that
contribute to complex traits. However, the presence
among the test results with nominal p < 0.001 for associ-
ation with QT interval duration of common variants at the
NOS1AP locus, a recently identified and multiply repli-
cated myocardial repolarization gene [20], supports the
presence of some true positive results among the mostly
false positive findings.
Strengths of our study include the moderate-sized, well-
characterized community-based sample, without ascer-
tainment on phenotype, and the precision of the ECG and
HRV measurements as supported by their substantial her-
itability. Some limitations pertain. Our study had limited
power to detect modest genetic effects in a single stage.
The Affymetrix 100K GeneChip, a first generation geno-
typing array, has patchy coverage of common genetic var-
iation, leaving many regions untested. Our sample is
almost exclusively of European ancestry, potentially limit-
ing extension to other populations with different linkage
disequilibrium patterns or environmental exposures.
Conclusion
Staged GWAS designs in which a modest number of
results from GWAS in the first stage are tested in a second
independent sample and the combined statistical evi-
dence considered, are powerful and efficient approaches
to identify common variants associated with complex
traits [29,30]. Such approaches may be warranted for fol-
low up of findings from this study. Through such
approaches we hope to find additional genetic factors that
could improve our understanding of human biology,
serve as targets for novel therapeutics or contribute to
improved identification of individuals at high risk for car-
diovascular events. Our report and the web posting of all
results from 70,987 SNPs tested for association with ECG
and HRV phenotypes in the Framingham Heart Study rep-
resents a first step in this endeavor.
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